TURBO / USDC

TURBO / TRY

TURBO / USDT

FUN / USDT

HAEDAL / BNB

BANANA / BNB

BANANA / USDT

BANANA / USDC

HAEDAL / FDUSD

BANANA / TRY

USUAL / BTC

USUAL / USDC

USUAL / USDT

USUAL / TRY

USUAL / FDUSD

HYPER / FDUSD

HYPER / BNB

KERNEL / BNB

DENT / ETH

BROCCOLI714 / USDT

BRIGHTCOM GROUP LIMITED

CAPITAL TRUST LTD

SMARTEN POWER SYSTEMS LTD

ASTEC LIFESCIENCES LTD

NEULAND LAB LTD.

VISAMAN GLOBAL SALES LTD

SUVIDHAA INFOSERVE LTD

OLA ELECTRIC MOBILITY LTD

B&B TRIPLEWALL CONT LTD

ABHA POWER N STEEL LTD

ADITYA ULTRA STEEL LTD

WONDER ELECTRICALS LTD

BAHETI RECYCLING IND LTD

SALONA COTSPIN LTD.

VERTOZ LIMITED

FALCON TECHNOPROJ IND LTD

GE POWER INDIA LIMITED

MIRC ELECTRONICS LTD

INFLUX HEALTHTECH LIMITED

GODHA CABCON INSULAT LTD

Click here to get full coverage on Senores Pharmaceuticals to increase stake in Havix - Indian Pharma Post

Senores Pharmaceuticals to increase stake in Havix  Indian Pharma Post

Senores Pharmaceuticals to increase stake in Havix - Indian Pharma Post

Click here to get full coverage on Senores Pharmaceuticals Receives ANDA Approval to Market Generic Enalapril Maleate Tablets for Hypertension and Heart Conditions - geneonline.com

Senores Pharmaceuticals Receives ANDA Approval to Market Generic Enalapril Maleate Tablets for Hypertension and Heart Conditions  geneonline.com

Senores Pharmaceuticals Receives ANDA Approval to Market Generic Enalapril Maleate Tablets for Hypertension and Heart Conditions - geneonline.com

Click here to get full coverage on Dr. Reddy’s sells 14 generic non-strategic assets to Senores Pharma for U.S. expansion - Drug Store News

Dr. Reddy’s sells 14 generic non-strategic assets to Senores Pharma for U.S. expansion  Drug Store News

Dr. Reddy’s sells 14 generic non-strategic assets to Senores Pharma for U.S. expansion - Drug Store News

Click here to get full coverage on Senores Pharmaceuticals Issues Corporate Guarantee for Subsidiary’s Credit Facility - TipRanks

Senores Pharmaceuticals Issues Corporate Guarantee for Subsidiary’s Credit Facility  TipRanks

Senores Pharmaceuticals Issues Corporate Guarantee for Subsidiary’s Credit Facility - TipRanks

Click here to get full coverage on Senores Pharma shares in focus after deal to acquire USFDA-approved epilepsy drug from Wockhardt - The Economic Times

Senores Pharma shares in focus after deal to acquire USFDA-approved epilepsy drug from Wockhardt  The Economic Times

Senores Pharma shares in focus after deal to acquire USFDA-approved epilepsy drug from Wockhardt - The Economic Times

Click here to get full coverage on Senores Pharmaceuticals faces $50,000 tax penalty from IRS - ETLegalWorld.com

Senores Pharmaceuticals faces $50,000 tax penalty from IRS  ETLegalWorld.com

Senores Pharmaceuticals faces $50,000 tax penalty from IRS - ETLegalWorld.com

Click here to get full coverage on Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market - Business Wire

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market  Business Wire

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market - Business Wire

Click here to get full coverage on Senores Pharmaceuticals Limited's (NSE:SENORES) Share Price Matching Investor Opinion - simplywall.st

Senores Pharmaceuticals Limited's (NSE:SENORES) Share Price Matching Investor Opinion  simplywall.st

Senores Pharmaceuticals Limited's (NSE:SENORES) Share Price Matching Investor Opinion - simplywall.st

Click here to get full coverage on Senores Pharmaceuticals appoints Gautam Shah as President of US operations - BioSpectrum India

Senores Pharmaceuticals appoints Gautam Shah as President of US operations  BioSpectrum India

Senores Pharmaceuticals appoints Gautam Shah as President of US operations - BioSpectrum India

Click here to get full coverage on Senores Pharmaceuticals Says Investment Of $468,640 In SPI Through Rights Issue - MarketScreener

Senores Pharmaceuticals Says Investment Of $468,640 In SPI Through Rights Issue  MarketScreener

Senores Pharmaceuticals Says Investment Of $468,640 In SPI Through Rights Issue - MarketScreener

Click here to get full coverage on Senores Pharmaceuticals zoom nearly 6% on entering into SPA to acquire 2.97% stake in Havix - Upstox

Senores Pharmaceuticals zoom nearly 6% on entering into SPA to acquire 2.97% stake in Havix  Upstox

Senores Pharmaceuticals zoom nearly 6% on entering into SPA to acquire 2.97% stake in Havix - Upstox

Click here to get full coverage on D-Street Debut: Senores Pharma Senores Pharmaceuticals Limited made a healthy stock market debut, with shares getting listed at ₹600, a 53.45% premium to its issue price of ₹391/share on the NSE. On the BSE, the stock made debut at ₹593.70/share, a 5 - LinkedIn

D-Street Debut: Senores Pharma Senores Pharmaceuticals Limited made a healthy stock market debut, with shares getting listed at ₹600, a 53.45% premium to its issue price of ₹391/share on the NSE. On the BSE, the stock made debut at ₹593.70/share, a 5  LinkedIn

D-Street Debut: Senores Pharma Senores Pharmaceuticals Limited made a healthy stock market debut, with shares getting listed at ₹600, a 53.45% premium to its issue price of ₹391/share on the NSE. On the BSE, the stock made debut at ₹593.70/share, a 5 - LinkedIn

Click here to get full coverage on Senores Pharmaceuticals IPO listing date today. GMP, experts signal up to 70% gain for share allottees - Mint

Senores Pharmaceuticals IPO listing date today. GMP, experts signal up to 70% gain for share allottees  Mint

Senores Pharmaceuticals IPO listing date today. GMP, experts signal up to 70% gain for share allottees - Mint

Click here to get full coverage on Dr Reddy’s sells 14-drug portfolio to Senores Pharma for US market expansion - CNBC TV18

Dr Reddy’s sells 14-drug portfolio to Senores Pharma for US market expansion  CNBC TV18

Dr Reddy’s sells 14-drug portfolio to Senores Pharma for US market expansion - CNBC TV18

Click here to get full coverage on US uncertainty: Senores Pharma treads, where other drugmakers wait with caution - BusinessLine

US uncertainty: Senores Pharma treads, where other drugmakers wait with caution  BusinessLine

US uncertainty: Senores Pharma treads, where other drugmakers wait with caution - BusinessLine

Click here to get full coverage on Senores receives ANDA approval for marketing Metoprolol Tartrate and Hydrochlorothiazide Tablet USP - Indian Pharma Post

Senores receives ANDA approval for marketing Metoprolol Tartrate and Hydrochlorothiazide Tablet USP  Indian Pharma Post

Senores receives ANDA approval for marketing Metoprolol Tartrate and Hydrochlorothiazide Tablet USP - Indian Pharma Post

Click here to get full coverage on Senores Pharmaceuticals IPO Day 1: Latest GMP, subscription status, review, other details. Apply or not? - Mint

Senores Pharmaceuticals IPO Day 1: Latest GMP, subscription status, review, other details. Apply or not?  Mint

Senores Pharmaceuticals IPO Day 1: Latest GMP, subscription status, review, other details. Apply or not? - Mint

Click here to get full coverage on Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals - Indian Pharma Post

Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals  Indian Pharma Post

Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals - Indian Pharma Post

Click here to get full coverage on Senores Pharmaceuticals Share Price Live: Senores Pharma shares drop 10% post debut; list at 53% premium ... - The Economic Times

Senores Pharmaceuticals Share Price Live: Senores Pharma shares drop 10% post debut; list at 53% premium ...  The Economic Times

Senores Pharmaceuticals Share Price Live: Senores Pharma shares drop 10% post debut; list at 53% premium ... - The Economic Times

Click here to get full coverage on Senores Pharma IPO subscribed 13.88 times on Day 2. Check GMP, key dates, price band - The Economic Times

Senores Pharma IPO subscribed 13.88 times on Day 2. Check GMP, key dates, price band  The Economic Times

Senores Pharma IPO subscribed 13.88 times on Day 2. Check GMP, key dates, price band - The Economic Times

Click here to get full coverage on Pharma stock with 100% net profit growth guidance for FY26 to keep an eye on - Trade Brains

Pharma stock with 100% net profit growth guidance for FY26 to keep an eye on  Trade Brains

Pharma stock with 100% net profit growth guidance for FY26 to keep an eye on - Trade Brains

Click here to get full coverage on US subsidiary of Senores Pharma appoints Gautam Shah as President of US Operations - Express Pharma

US subsidiary of Senores Pharma appoints Gautam Shah as President of US Operations  Express Pharma

US subsidiary of Senores Pharma appoints Gautam Shah as President of US Operations - Express Pharma

Click here to get full coverage on Senores Pharma US arm ropes in Gautam Shah as President of US Operations - Medical Dialogues

Senores Pharma US arm ropes in Gautam Shah as President of US Operations  Medical Dialogues

Senores Pharma US arm ropes in Gautam Shah as President of US Operations - Medical Dialogues

Click here to get full coverage on IPO GMP: Senores Pharmaceuticals, Ventive Hospitality to Unimech Aerospace — what GMP signals ahead of listing date - Mint

IPO GMP: Senores Pharmaceuticals, Ventive Hospitality to Unimech Aerospace — what GMP signals ahead of listing date  Mint

IPO GMP: Senores Pharmaceuticals, Ventive Hospitality to Unimech Aerospace — what GMP signals ahead of listing date - Mint

Click here to get full coverage on Anar Modi named CHO at Senores Pharma - Medical Dialogues

Anar Modi named CHO at Senores Pharma  Medical Dialogues

Anar Modi named CHO at Senores Pharma - Medical Dialogues

Click here to get full coverage on Senores Pharmaceuticals receives USFDA approval for Metoprolol Tartrate and Hydrochlorothiazide Tablet - Business Standard

Senores Pharmaceuticals receives USFDA approval for Metoprolol Tartrate and Hydrochlorothiazide Tablet  Business Standard

Senores Pharmaceuticals receives USFDA approval for Metoprolol Tartrate and Hydrochlorothiazide Tablet - Business Standard

Click here to get full coverage on Senores Pharmaceuticals IPO Day 3 Highlights: Issue booked 93.41 times on third day; check GMP & other details - Mint

Senores Pharmaceuticals IPO Day 3 Highlights: Issue booked 93.41 times on third day; check GMP & other details  Mint

Senores Pharmaceuticals IPO Day 3 Highlights: Issue booked 93.41 times on third day; check GMP & other details - Mint

Click here to get full coverage on Dr Reddy's Labs sells 14 ANDAs to Senores Pharma - Medical Dialogues

Dr Reddy's Labs sells 14 ANDAs to Senores Pharma  Medical Dialogues

Dr Reddy's Labs sells 14 ANDAs to Senores Pharma - Medical Dialogues

Click here to get full coverage on Senores Pharma shares jump over 7% as company acquires 14 ANDAs from Dr. Reddy’s - Moneycontrol

Senores Pharma shares jump over 7% as company acquires 14 ANDAs from Dr. Reddy’s  Moneycontrol

Senores Pharma shares jump over 7% as company acquires 14 ANDAs from Dr. Reddy’s - Moneycontrol

Click here to get full coverage on IPO lock-in expiry: Senores Pharmaceutical, Ventive Hospitality, Carraro India crack 8% as shares freed up... - Moneycontrol

IPO lock-in expiry: Senores Pharmaceutical, Ventive Hospitality, Carraro India crack 8% as shares freed up...  Moneycontrol

IPO lock-in expiry: Senores Pharmaceutical, Ventive Hospitality, Carraro India crack 8% as shares freed up... - Moneycontrol

Click here to get full coverage on Senores Pharmaceuticals IPO GMP Hints At Strong Listing Gain Before Launch - NDTV Profit

Senores Pharmaceuticals IPO GMP Hints At Strong Listing Gain Before Launch  NDTV Profit

Senores Pharmaceuticals IPO GMP Hints At Strong Listing Gain Before Launch - NDTV Profit

Click here to get full coverage on Senores Pharmaceuticals IPO listing bonanza: shares debut at 53% premium, pare gains at close - Moneycontrol

Senores Pharmaceuticals IPO listing bonanza: shares debut at 53% premium, pare gains at close  Moneycontrol

Senores Pharmaceuticals IPO listing bonanza: shares debut at 53% premium, pare gains at close - Moneycontrol

Click here to get full coverage on Senores Pharmaceuticals reports revenue of Rs. 288 crore in 9M FY25 - Indian Pharma Post

Senores Pharmaceuticals reports revenue of Rs. 288 crore in 9M FY25  Indian Pharma Post

Senores Pharmaceuticals reports revenue of Rs. 288 crore in 9M FY25 - Indian Pharma Post

Click here to get full coverage on Senores Pharmaceuticals IPO allotment status out. Latest GMP, how to check status online - Mint

Senores Pharmaceuticals IPO allotment status out. Latest GMP, how to check status online  Mint

Senores Pharmaceuticals IPO allotment status out. Latest GMP, how to check status online - Mint

Click here to get full coverage on Unimech Aerospace and Senores Pharmaceuticals Announce IPOs - Deccan Chronicle

Unimech Aerospace and Senores Pharmaceuticals Announce IPOs  Deccan Chronicle

Unimech Aerospace and Senores Pharmaceuticals Announce IPOs - Deccan Chronicle

Click here to get full coverage on Senores Pharmaceuticals consolidated net profit rises 11.86% in the March 2025 quarter - Business Standard

Senores Pharmaceuticals consolidated net profit rises 11.86% in the March 2025 quarter  Business Standard

Senores Pharmaceuticals consolidated net profit rises 11.86% in the March 2025 quarter - Business Standard

Click here to get full coverage on Senores Pharmaceuticals share price dips over 6% after strong debut in Indian stock market. Buy, sell or hold? - Mint

Senores Pharmaceuticals share price dips over 6% after strong debut in Indian stock market. Buy, sell or hold?  Mint

Senores Pharmaceuticals share price dips over 6% after strong debut in Indian stock market. Buy, sell or hold? - Mint

Click here to get full coverage on IPO GMP Of Unimech Aerospace And Senores Pharmaceuticals Soars Ahead Of Listing Next Week - NDTV Profit

IPO GMP Of Unimech Aerospace And Senores Pharmaceuticals Soars Ahead Of Listing Next Week  NDTV Profit

IPO GMP Of Unimech Aerospace And Senores Pharmaceuticals Soars Ahead Of Listing Next Week - NDTV Profit

Click here to get full coverage on Senores Pharmaceuticals Share Price Highlights: Stock ends 6% below listing price but 43% above IPO price - Mint

Senores Pharmaceuticals Share Price Highlights: Stock ends 6% below listing price but 43% above IPO price  Mint

Senores Pharmaceuticals Share Price Highlights: Stock ends 6% below listing price but 43% above IPO price - Mint

Click here to get full coverage on Senores Pharmaceuticals IPO: Latest subscription status, GMP; listing date - India Today

Senores Pharmaceuticals IPO: Latest subscription status, GMP; listing date  India Today

Senores Pharmaceuticals IPO: Latest subscription status, GMP; listing date - India Today

Click here to get full coverage on Senores Pharma IPO: GMP, subscription status, review, other details. Apply or not? - Mint

Senores Pharma IPO: GMP, subscription status, review, other details. Apply or not?  Mint

Senores Pharma IPO: GMP, subscription status, review, other details. Apply or not? - Mint

Click here to get full coverage on Senores Pharmaceuticals IPO day 3: GMP, subscription status to review. Apply or not? - Mint

Senores Pharmaceuticals IPO day 3: GMP, subscription status to review. Apply or not?  Mint

Senores Pharmaceuticals IPO day 3: GMP, subscription status to review. Apply or not? - Mint

Click here to get full coverage on Why Senores Pharma Share Price is Rising - Equitymaster

Why Senores Pharma Share Price is Rising  Equitymaster

Why Senores Pharma Share Price is Rising - Equitymaster

Click here to get full coverage on Senores Pharma appoints Jignesh Desai as President - Finance - Medical Dialogues

Senores Pharma appoints Jignesh Desai as President - Finance  Medical Dialogues

Senores Pharma appoints Jignesh Desai as President - Finance - Medical Dialogues

Click here to get full coverage on Senores Pharmaceuticals expands operations with 2nd API manufacturing facility - Healthcare Radius

Senores Pharmaceuticals expands operations with 2nd API manufacturing facility  Healthcare Radius

Senores Pharmaceuticals expands operations with 2nd API manufacturing facility - Healthcare Radius

Click here to get full coverage on Senores Pharma Standalone March 2025 Net Sales at Rs 11.86 crore, down 65.13% Y-o-Y - Moneycontrol

Senores Pharma Standalone March 2025 Net Sales at Rs 11.86 crore, down 65.13% Y-o-Y  Moneycontrol

Senores Pharma Standalone March 2025 Net Sales at Rs 11.86 crore, down 65.13% Y-o-Y - Moneycontrol

Click here to get full coverage on Senores Pharmaceuticals Lists At Premium Of 53% Over IPO Price - NDTV Profit

Senores Pharmaceuticals Lists At Premium Of 53% Over IPO Price  NDTV Profit

Senores Pharmaceuticals Lists At Premium Of 53% Over IPO Price - NDTV Profit

Click here to get full coverage on Senores Pharmaceuticals appoints Gautam Shah as president of US operations - Pharmabiz.com

Senores Pharmaceuticals appoints Gautam Shah as president of US operations  Pharmabiz.com

Senores Pharmaceuticals appoints Gautam Shah as president of US operations - Pharmabiz.com

Click here to get full coverage on Senores Pharma outlines inorganic strategy to expand product pipeline - VCCircle

Senores Pharma outlines inorganic strategy to expand product pipeline  VCCircle

Senores Pharma outlines inorganic strategy to expand product pipeline - VCCircle

Click here to get full coverage on Senores Pharmaceuticals to acquire 14 ANDAs from Dr Reddy's - Business Standard

Senores Pharmaceuticals to acquire 14 ANDAs from Dr Reddy's  Business Standard

Senores Pharmaceuticals to acquire 14 ANDAs from Dr Reddy's - Business Standard

Click here to get full coverage on Senores Pharmaceuticals IPO: Should you subscribe? Check GMP, subscription - India Today

Senores Pharmaceuticals IPO: Should you subscribe? Check GMP, subscription  India Today

Senores Pharmaceuticals IPO: Should you subscribe? Check GMP, subscription - India Today

Click here to get full coverage on Senores Pharmaceuticals Raises Rs 261 Crore From Anchor Investors Prior To IPO Launch - NDTV Profit

Senores Pharmaceuticals Raises Rs 261 Crore From Anchor Investors Prior To IPO Launch  NDTV Profit

Senores Pharmaceuticals Raises Rs 261 Crore From Anchor Investors Prior To IPO Launch - NDTV Profit

Click here to get full coverage on Senores Pharmaceuticals Day 1 Updates: Issue subscribed 1.86 times, GMP at ₹180 - Mint

Senores Pharmaceuticals Day 1 Updates: Issue subscribed 1.86 times, GMP at ₹180  Mint

Senores Pharmaceuticals Day 1 Updates: Issue subscribed 1.86 times, GMP at ₹180 - Mint

Click here to get full coverage on Senores Pharmaceuticals acquires 14 ANDAs from Dr Reddy’s - Healthcare Radius

Senores Pharmaceuticals acquires 14 ANDAs from Dr Reddy’s  Healthcare Radius

SENORES PHARMACEUTICALS L (SENORES)

Price Chart

Key Statistics

Technicals

About SENORES

Latest News

Senores Pharmaceuticals to increase stake in Havix - Indian Pharma Post

Senores Pharmaceuticals Receives ANDA Approval to Market Generic Enalapril Maleate Tablets for Hypertension and Heart Conditions - geneonline.com

Dr. Reddy’s sells 14 generic non-strategic assets to Senores Pharma for U.S. expansion - Drug Store News

Advanced Charts

Top Gainers

Top Losers